RxDoctor Payments Data

Kali McKenzie, APRN

Family · Greenville, KYNPI 1518669100

Payments from drug & device makers

$2,275in general payments, 2019–2025

Across 138 payments — averaging $16.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$531
  • Amgen$387
  • Merck$375
  • Esperion Therapeutics, Inc.$193
  • Boehringer Ingelheim$173
  • Bayer$135
  • plus $480 from 10 others

What the payments were for

  • Food & beverage$2,275100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,275 in reported general payments places this provider in the 80th percentile of 4,374 family providers in Kentucky.

See all family providers in Kentucky

Medicare billing

Part B allowed, 2024
$32,072
Medicare patients
146
Services billed
372

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EntrestoSacubitril/Valsartan82$65,658
EliquisApixaban81$61,165
JardianceEmpagliflozin70$53,103
FarxigaDapagliflozin Propanediol49$34,176
VerquvoVericiguat19$22,770
Repatha SureclickEvolocumab24$16,153
XareltoRivaroxaban19$14,706
BrilintaTicagrelor11$6,517
Metoprolol Succinate362$2,856
Nitroglycerin PatchNitroglycerin88$2,345
Digoxin59$1,102
Spironolactone185$924
Ranolazine ErRanolazine14$806
Rosuvastatin Calcium81$707
Ezetimibe79$688

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
NovartisEntresto$531$65,65882 claims
Boehringer IngelheimJardiance$173$53,10370 claims
AstraZenecaFarxiga, Brilinta$48$40,69360 claims
MerckVerquvo$375$22,77019 claims
Johnson & JohnsonXarelto$65$14,70619 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 4,374 family providers in Kentucky.

Other family in Greenville

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →